Global Small Molecule Targeted Cancer Therapy Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Small Molecule Targeted Cancer Therapy Global Market Report 2025

Name: Small Molecule Targeted Cancer Therapy Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Therapy Type (Tyrosine Kinase Inhibitors, Proteasome Inhibitors, Histone Deacetylase Inhibitors, PARP Inhibitors, Other Small Molecule Inhibitors); By Cancer Type (Lung Cancer, Breast Cancer, Other Cancer Types); By Mode Of Administration (Oral, Intravenous, Other Modes); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Direct Sales); By End User (Hospitals, Specialty Clinics, Research Institutes, Other End Users); Subsegments:; By Tyrosine Kinase Inhibitors (EGFR Inhibitors, VEGFR Inhibitors, ALK Inhibitors, BCR-ABL Inhibitors, HER2 Inhibitors); By Proteasome Inhibitors (Bortezomib, Carfilzomib, Ixazomib); By CDK Inhibitors (CDK4/6 Inhibitors, CDK1/2 Inhibitors, Pan-CDK Inhibitors) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Small Molecule Targeted Cancer Therapy Market Overview

• Small Molecule Targeted Cancer Therapy market size has reached to $78.07 billion in 2024

• Expected to grow to $120.35 billion in 2029 at a compound annual growth rate (CAGR) of 9%

• Growth Driver: Growing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Need For Tailored And Effective Treatments

• Market Trend: Oral Targeted Therapies Showing Promising Clinical Results Boosting Market Growth

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Small Molecule Targeted Cancer Therapy Market?

Small molecule targeted cancer therapy is a type of cancer treatment that uses low-molecular-weight compounds to specifically target cancer cell proteins or pathways, inhibiting tumor growth while minimizing damage to healthy cells. Its purpose is to provide precise, effective, and personalized treatment options that improve patient outcomes and reduce the side effects associated with conventional chemotherapy.

The main therapy types of small molecule targeted cancer therapy include tyrosine kinase inhibitors, proteasome inhibitors, histone deacetylase inhibitors, PARP inhibitors, CDK inhibitors, BCL-2 inhibitors, mTOR inhibitors, and others. Tyrosine kinase inhibitors refer to targeted compounds designed to block specific enzymes involved in cancer cell growth and proliferation, providing precise therapeutic effects with reduced systemic toxicity. These therapies are used across cancer types such as lung cancer, breast cancer, colorectal cancer, leukemia, prostate cancer, and others. They are administered via oral, intravenous, and others, distributed through hospital pharmacies, retail pharmacies, online pharmacies, and direct sales, with key end-users including hospitals, specialty clinics, research institutes, and others.

Small Molecule Targeted Cancer Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Small Molecule Targeted Cancer Therapy Market Size 2025 And Growth Rate?

What Is The Small Molecule Targeted Cancer Therapy Market Growth Forecast?

The small molecule targeted cancer therapy market size is expected to see strong growth in the next few years. It will grow to $120.35 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for precision oncology, rising investment in next-generation inhibitors, rising healthcare expenditure in emerging markets, increasing demand for the therapies, and growing strategic collaborations. Major trends in the forecast period include a focus on tumor-agnostic therapies, the development of allosteric modulators, the adoption of artificial intelligence in drug discovery, the adoption of oral targeted therapies, and a shift towards combination treatment strategies.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Small Molecule Targeted Cancer Therapy Market Segmented?

1) By Therapy Type: Tyrosine Kinase Inhibitors, Proteasome Inhibitors, Histone Deacetylase Inhibitors, PARP Inhibitors, CDK Inhibitors, BCL-2 Inhibitors, mTOR Inhibitors, Other Small Molecule Inhibitors

2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Cancer Types

3) By Mode Of Administration: Oral, Intravenous, Other Modes

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Direct Sales

5) By End User: Hospitals, Specialty Clinics, Research Institutes, Other End Users

Subsegment:

1) By Tyrosine Kinase Inhibitors: EGFR Inhibitors, VEGFR Inhibitors, ALK Inhibitors, BCR-ABL Inhibitors, HER2 Inhibitors

2) By Proteasome Inhibitors: Bortezomib, Carfilzomib, Ixazomib

3) By Histone Deacetylase Inhibitors: Pan-Histone Deacetylase Inhibitors, Class-specific Histone Deacetylase Inhibitors

4) By PARP Inhibitors: Olaparib, Niraparib, Rucaparib, Talazoparib

5) By CDK Inhibitors: CDK4/6 Inhibitors, CDK1/2 Inhibitors, Pan-CDK Inhibitors

6) By BCL-2 Inhibitors: Venetoclax, Navitoclax

7) By mTOR Inhibitors: Rapamycin Analogs (Rapalogs), ATP-competitive mTOR Inhibitors, Dual mTOR/PI3K Inhibitors

8) By Other Small Molecule Inhibitors: MEK Inhibitors, PI3K Inhibitors, RAF Inhibitors

What Is Driving The Small Molecule Targeted Cancer Therapy Market? Growing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Need For Tailored And Effective Treatments

The growing demand for personalized medicine is expected to propel the growth of the small molecule targeted therapy market going forward. Personalized medicine refers to a medical approach that tailors the prevention, diagnosis, and treatment of diseases to the individual characteristics of each patient. The demand for personalized medicine is rising due to the growing need for targeted treatments that improve efficacy and reduce adverse effects. Small molecule targeted therapy helps address the demand for personalized medicine by enhancing treatment specificity, improving patient response, minimizing side effects, and enabling therapies tailored to individual genetic and molecular profiles. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the US Food and Drug Administration (FDA) granted approval for 16 new personalized treatments for rare disease patients, marking a substantial increase from the six approvals in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the small molecule targeted therapy market.

Who Are The Major Players In The Global Small Molecule Targeted Cancer Therapy Market?

Major companies operating in the small molecule targeted cancer therapy market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis International AG, AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., and Ipsen Biopharmaceuticals Inc.

What Are The Key Trends Of The Global Small Molecule Targeted Cancer Therapy Market? Oral Targeted Therapies Showing Promising Clinical Results Boosting Market Growth

Major companies operating in the small molecule targeted cancer therapy market are focusing on innovative therapy, such as structure-based drug design, to develop highly selective inhibitors that target specific oncogenic mutations, minimize off-target effects, and improve patient outcomes. Structure-based drug design is a method that uses the 3D structure of a target protein to design small molecules that bind precisely to it, improving drug effectiveness and reducing side effects. For instance, in December 2022, Mirati Therapeutics, a US-based oncology company, announced KRAZATI (adagrasib) as a targeted therapy for adult patients with KRAS G12C-mutated locally advanced or metastatic NSCLC who have received at least one prior systemic therapy approved by the U.S. Food and Drug Administration (FDA), a US-based government agency. This approval provides a new treatment option for patients with difficult-to-treat KRAS G12C-mutated non-small cell lung cancer, addressing an important unmet medical need. KRAZATI works by selectively inhibiting the KRAS G12C mutant protein, which is involved in cancer cell proliferation and survival.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Small Molecule Targeted Cancer Therapy Market? Eli Lilly And Company Acquires Siteone Therapeutics Inc. To Expand Chronic Pain Treatment Portfolio

In May 2023, Gilead Sciences, Inc., a US-based biopharmaceutical company, acquired XinThera Inc. for an undisclosed amount. With this acquisition, Gilead Sciences aims to strengthen its oncology and inflammation pipeline by adding XinThera’s small molecule inhibitors targeting PARP1 and MK2, expanding its portfolio of precision medicines. XinThera Inc. is a US-based biotechnology company specializing in developing small molecule therapies for oncology and immunology.

What Is The Regional Outlook For The Global Small Molecule Targeted Cancer Therapy Market?

North America was the largest region in the small molecule targeted cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Small Molecule Targeted Cancer Therapy Market?

The small molecule targeted cancer therapy market consists of sales of novel agents, venetoclax, imatinib, olaparib, niraparib. Values in this market are ‘factory gate’ values, meaning the value of goods sold by the manufacturers or creators of the drugs, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market also includes related services provided by the creators of these therapies.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Small Molecule Targeted Cancer Therapy Industry?

The small molecule targeted cancer therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule targeted cancer therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

1. Executive Summary

2. Small Molecule Targeted Cancer Therapy Market Characteristics

3. Small Molecule Targeted Cancer Therapy Market Trends And Strategies

4. Small Molecule Targeted Cancer Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Small Molecule Targeted Cancer Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Small Molecule Targeted Cancer Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Small Molecule Targeted Cancer Therapy Market Growth Rate Analysis

5.4. Global Small Molecule Targeted Cancer Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Small Molecule Targeted Cancer Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Small Molecule Targeted Cancer Therapy Total Addressable Market (TAM)

6. Small Molecule Targeted Cancer Therapy Market Segmentation

6.1. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tyrosine Kinase Inhibitors

Proteasome Inhibitors

Histone Deacetylase Inhibitors

PARP Inhibitors

CDK Inhibitors

BCL-2 Inhibitors

mTOR Inhibitors

Other Small Molecule Inhibitors

6.2. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Cancer

Breast Cancer

Colorectal Cancer

Leukemia

Prostate Cancer

Other Cancer Types

6.3. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Other Modes

6.4. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Direct Sales

6.5. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Research Institutes

Other End Users

6.6. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Tyrosine Kinase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

EGFR Inhibitors

VEGFR Inhibitors

ALK Inhibitors

BCR-ABL Inhibitors

HER2 Inhibitors

6.7. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Proteasome Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bortezomib

Carfilzomib

Ixazomib

6.8. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Histone Deacetylase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pan-Histone Deacetylase Inhibitors

Class-specific Histone Deacetylase Inhibitors

6.9. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of PARP Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Olaparib

Niraparib

Rucaparib

Talazoparib

6.10. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of CDK Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CDK4/6 Inhibitors

CDK1/2 Inhibitors

Pan-CDK Inhibitors

6.11. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of BCL-2 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Venetoclax

Navitoclax

6.12. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of mTOR Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rapamycin Analogs (Rapalogs)

ATP-competitive mTOR inhibitors

Dual mTOR Or PI3K Inhibitors

6.13. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Other Small Molecule Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

MEK Inhibitors

PI3K Inhibitors

RAF Inhibitors

7. Small Molecule Targeted Cancer Therapy Market Regional And Country Analysis

7.1. Global Small Molecule Targeted Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Small Molecule Targeted Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule Targeted Cancer Therapy Market

8.1. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule Targeted Cancer Therapy Market

9.1. China Small Molecule Targeted Cancer Therapy Market Overview

9.2. China Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule Targeted Cancer Therapy Market

10.1. India Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule Targeted Cancer Therapy Market

11.1. Japan Small Molecule Targeted Cancer Therapy Market Overview

11.2. Japan Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule Targeted Cancer Therapy Market

12.1. Australia Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule Targeted Cancer Therapy Market

13.1. Indonesia Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule Targeted Cancer Therapy Market

14.1. South Korea Small Molecule Targeted Cancer Therapy Market Overview

14.2. South Korea Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule Targeted Cancer Therapy Market

15.1. Western Europe Small Molecule Targeted Cancer Therapy Market Overview

15.2. Western Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule Targeted Cancer Therapy Market

16.1. UK Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule Targeted Cancer Therapy Market

17.1. Germany Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule Targeted Cancer Therapy Market

18.1. France Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule Targeted Cancer Therapy Market

19.1. Italy Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule Targeted Cancer Therapy Market

20.1. Spain Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule Targeted Cancer Therapy Market

21.1. Eastern Europe Small Molecule Targeted Cancer Therapy Market Overview

21.2. Eastern Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule Targeted Cancer Therapy Market

22.1. Russia Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule Targeted Cancer Therapy Market

23.1. North America Small Molecule Targeted Cancer Therapy Market Overview

23.2. North America Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule Targeted Cancer Therapy Market

24.1. USA Small Molecule Targeted Cancer Therapy Market Overview

24.2. USA Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule Targeted Cancer Therapy Market

25.1. Canada Small Molecule Targeted Cancer Therapy Market Overview

25.2. Canada Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule Targeted Cancer Therapy Market

26.1. South America Small Molecule Targeted Cancer Therapy Market Overview

26.2. South America Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule Targeted Cancer Therapy Market

27.1. Brazil Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule Targeted Cancer Therapy Market

28.1. Middle East Small Molecule Targeted Cancer Therapy Market Overview

28.2. Middle East Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule Targeted Cancer Therapy Market

29.1. Africa Small Molecule Targeted Cancer Therapy Market Overview

29.2. Africa Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule Targeted Cancer Therapy Market Competitive Landscape And Company Profiles

30.1. Small Molecule Targeted Cancer Therapy Market Competitive Landscape

30.2. Small Molecule Targeted Cancer Therapy Market Company Profiles

30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule Targeted Cancer Therapy Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Sanofi S.A.

31.3. Novartis International AG

31.4. AstraZeneca plc

31.5. Bristol-Myers Squibb Company

31.6. GlaxoSmithKline plc (GSK)

31.7. Eli Lilly and Company

31.8. Takeda Pharmaceutical Company Limited

31.9. Amgen Inc.

31.10. Gilead Sciences Inc.

31.11. Boehringer Ingelheim International GmbH

31.12. Astellas Pharma Inc.

31.13. Daiichi Sankyo Company Limited

31.14. Eisai Co. Ltd.

31.15. Ipsen Biopharmaceuticals Inc.

32. Global Small Molecule Targeted Cancer Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule Targeted Cancer Therapy Market

34. Recent Developments In The Small Molecule Targeted Cancer Therapy Market

35. Small Molecule Targeted Cancer Therapy Market High Potential Countries, Segments and Strategies

35.1 Small Molecule Targeted Cancer Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Small Molecule Targeted Cancer Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Small Molecule Targeted Cancer Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Tyrosine Kinase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Proteasome Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Histone Deacetylase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of PARP Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of CDK Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of BCL-2 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of mTOR Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Other Small Molecule Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Global Small Molecule Targeted Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Global Small Molecule Targeted Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Asia-Pacific, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Asia-Pacific, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Asia-Pacific, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: China, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: China, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: China, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: India, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: India, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: India, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Japan, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Japan, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Japan, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Australia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Australia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Australia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Indonesia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Indonesia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Indonesia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: South Korea, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: South Korea, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: South Korea, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Western Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Western Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Western Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: UK, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: UK, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: UK, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Germany, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Germany, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Germany, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: France, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: France, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: France, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Italy, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Italy, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Italy, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Spain, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Spain, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Spain, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Eastern Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Eastern Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Eastern Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Russia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Russia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Russia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: North America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: North America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: North America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: USA, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: USA, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: USA, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Canada, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Canada, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Canada, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: South America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: South America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: South America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Brazil, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Brazil, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Brazil, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Middle East, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Middle East, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Middle East, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Africa, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 82: Africa, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 83: Africa, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 84: Johnson & Johnson Services Inc. Financial Performance

Table 85: F. Hoffmann-La Roche Ltd. Financial Performance

Table 86: Merck & Co. Inc. Financial Performance

Table 87: Pfizer Inc. Financial Performance

Table 88: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Small Molecule Targeted Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Tyrosine Kinase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Proteasome Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Histone Deacetylase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of PARP Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of CDK Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of BCL-2 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of mTOR Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Other Small Molecule Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Global Small Molecule Targeted Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Global Small Molecule Targeted Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Asia-Pacific, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Asia-Pacific, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Asia-Pacific, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: China, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: China, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: China, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: India, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: India, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: India, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Japan, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Japan, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Japan, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Australia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Australia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Australia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Indonesia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Indonesia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Indonesia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: South Korea, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: South Korea, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: South Korea, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Western Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Western Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Western Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: UK, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: UK, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: UK, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Germany, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Germany, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Germany, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: France, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: France, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: France, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Italy, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Italy, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Italy, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Spain, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Spain, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Spain, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Eastern Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Eastern Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Eastern Europe, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Russia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Russia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Russia, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: North America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: North America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: North America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: USA, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: USA, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: USA, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Canada, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Canada, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Canada, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: South America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: South America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: South America, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Brazil, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Brazil, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Brazil, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Middle East, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Middle East, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Middle East, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Africa, Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 82: Africa, Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 83: Africa, Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 84: Johnson & Johnson Services Inc. Financial Performance

Figure 85: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 86: Merck & Co. Inc. Financial Performance

Figure 87: Pfizer Inc. Financial Performance

Figure 88: AbbVie Inc. Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Small Cell Lung Cancer Therapeutics Global Market Report 2025 – By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy, Other Tre...

RNA Targeting Small Molecules Therapeutics Global Market Report 2025 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Ta...

RNA Targeting Small Molecule Drug Discovery Global Market Report 2025 – By Target RNA Type (Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)), By Technology (CRISPR-Cas9, RNA A...

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2025 – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Oth...

Targeted Therapy Global Market Report 2025 – By Type (Small Molecule Medicines, Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Breast Cancer, ...

Small Molecule Injectable Drugs Global Market Report 2025 – By Drug Class (Small Molecule Antibiotics, Analgesics, Chemotherapy, Antivirals, Anticoagulant, Skeletal Muscle Relaxants, Anticonvulsants, Other Drug Class), B...

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2025 – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Oth...

Frequently Asked Questions

What is the definition of the Small Molecule Targeted Cancer Therapy market?

How will the Small Molecule Targeted Cancer Therapy market drivers and restraints affect the market dynamics? What forces will shape the Small Molecule Targeted Cancer Therapy industry going forward?

The market major growth driver - Growing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Need For Tailored And Effective Treatments. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Small Molecule Targeted Cancer Therapy market?

The small molecule targeted cancer therapy market size has grown strongly in recent years. It will grow from $78.07 billion in 2024 to $85.35 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing better understanding of cancer biology, rising approval of inhibitors, rising cancer prevalence, rising early adoption of personalized medicine, and expansion of oncology clinical trials. The small molecule targeted cancer therapy market size is expected to see strong growth in the next few years. It will grow to $120.35 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for precision oncology, rising investment in next-generation inhibitors, rising healthcare expenditure in emerging markets, increasing demand for the therapies, and growing strategic collaborations. Major trends in the forecast period include a focus on tumor-agnostic therapies, the development of allosteric modulators, the adoption of artificial intelligence in drug discovery, the adoption of oral targeted therapies, and a shift towards combination treatment strategies. For further insights on this market, request a sample here

How is the Small Molecule Targeted Cancer Therapy market segmented?

The small molecule targeted cancer therapy market covered in this report is segmented as
1) By Therapy Type: Tyrosine Kinase Inhibitors, Proteasome Inhibitors, Histone Deacetylase Inhibitors, PARP Inhibitors, CDK Inhibitors, BCL-2 Inhibitors, mTOR Inhibitors, Other Small Molecule Inhibitors
2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Cancer Types
3) By Mode Of Administration: Oral, Intravenous, Other Modes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Direct Sales
5) By End User: Hospitals, Specialty Clinics, Research Institutes, Other End Users Subsegment:
1) By Tyrosine Kinase Inhibitors: EGFR Inhibitors, VEGFR Inhibitors, ALK Inhibitors, BCR-ABL Inhibitors, HER2 Inhibitors
2) By Proteasome Inhibitors: Bortezomib, Carfilzomib, Ixazomib
3) By Histone Deacetylase Inhibitors: Pan-Histone Deacetylase Inhibitors, Class-specific Histone Deacetylase Inhibitors
4) By PARP Inhibitors: Olaparib, Niraparib, Rucaparib, Talazoparib
5) By CDK Inhibitors: CDK4/6 Inhibitors, CDK1/2 Inhibitors, Pan-CDK Inhibitors
6) By BCL-2 Inhibitors: Venetoclax, Navitoclax
7) By mTOR Inhibitors: Rapamycin Analogs (Rapalogs), ATP-competitive mTOR Inhibitors, Dual mTOR/PI3K Inhibitors
8) By Other Small Molecule Inhibitors: MEK Inhibitors, PI3K Inhibitors, RAF Inhibitors For further insights on this market, request a sample here

Which region has the largest share of the Small Molecule Targeted Cancer Therapy market? What are the other regions covered in the report?

North America was the largest region in the small molecule targeted cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in small molecule targeted cancer therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Small Molecule Targeted Cancer Therapy market?

What are the key trends in the Small Molecule Targeted Cancer Therapy market?

Major trends in this market include Oral Targeted Therapies Showing Promising Clinical Results Boosting Market Growth For further insights on this market, request a sample here.